Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer
- PMID: 28543055
- PMCID: PMC7523389
- DOI: 10.1002/jso.24690
Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer
Abstract
Background and objectives: To examine characteristics and survival outcome of women with endometrial cancer who declined postoperative radiotherapy.
Methods: A retrospective study was conducted to examine surgically-treated grade 1-2 stage IB and grade 3 stage IA-IB endometrioid endometrial cancer in the Surveillance, Epidemiology, and End Results Program between 1983 and 2013 (n = 10 613). Associations of patient declination for guideline-based postoperative radiotherapy and clinico-pathological demographics or survival outcome were examined on multivariable analysis.
Results: There were 323 (3.0%) women who declined adjuvant radiotherapy. Women who declined postoperative radiotherapy were more likely to be older, White, Western U.S. residents, and register in recent years (all, adjusted-P < 0.05). On multivariable analysis, patient declination for guideline-based postoperative radiotherapy remained an independent prognostic factor for decreased endometrial cancer-specific survival in unstaged grade 1-2 stage IB or staged/unstated grade 3 stage IA-IB diseases (adjusted-hazard ratio 1.84, 95% confidence interval 1.34-2.51, P = 0.001). Association of patient declination for guideline-based postoperative radiotherapy and decreased overall survival remained independent in the entire cohort on multivariable analysis (adjuvant-hazard ratio 1.71, 95% confidence interval 1.44-2.02, P < 0.001).
Conclusions: Our study suggested that patient compliance to guideline-based postoperative radiotherapy is a prognostic factor for women with stage I endometrioid endometrial cancer.
Keywords: adjuvant radiotherapy; compliance; endometrial cancer; survival outcome.
© 2017 Wiley Periodicals, Inc.
Conflict of interest statement
DISCLOSURE
There is no conflict of interest in all the authors.
Figures



Similar articles
-
Defining the survival benefit of adjuvant pelvic radiotherapy and chemotherapy versus chemotherapy alone in stages III-IVA endometrial carcinoma.Gynecol Oncol. 2019 Sep;154(3):487-494. doi: 10.1016/j.ygyno.2019.06.020. Epub 2019 Jun 28. Gynecol Oncol. 2019. PMID: 31257010
-
Prognosis of women with apparent stage I endometrial cancer who had supracervical hysterectomy.Gynecol Oncol. 2017 Apr;145(1):41-49. doi: 10.1016/j.ygyno.2017.02.004. Epub 2017 Feb 17. Gynecol Oncol. 2017. PMID: 28215841 Free PMC article.
-
Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.Eur J Cancer. 2020 Jul;133:33-46. doi: 10.1016/j.ejca.2020.03.031. Epub 2020 May 17. Eur J Cancer. 2020. PMID: 32434109 Free PMC article.
-
Improving oncologic outcomes for women with endometrial cancer: realigning our sights.Gynecol Oncol. 2014 May;133(2):370-4. doi: 10.1016/j.ygyno.2014.02.019. Epub 2014 Feb 20. Gynecol Oncol. 2014. PMID: 24561031 Free PMC article. Review.
-
Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors.Curr Oncol Rep. 2019 Jul 31;21(9):83. doi: 10.1007/s11912-019-0825-z. Curr Oncol Rep. 2019. PMID: 31367798 Free PMC article. Review.
Cited by
-
Defining Radiation Treatment Interruption Rates During the COVID-19 Pandemic: Findings From an Academic Center in an Underserved Urban Setting.Int J Radiat Oncol Biol Phys. 2023 Jun 1;116(2):379-393. doi: 10.1016/j.ijrobp.2022.09.073. Epub 2022 Sep 30. Int J Radiat Oncol Biol Phys. 2023. PMID: 36183931 Free PMC article.
-
Characteristics and survival of patients with gynecological cancers who refuse radiotherapy: a retrospective cohort study.BMC Womens Health. 2023 Nov 1;23(1):562. doi: 10.1186/s12905-023-02720-6. BMC Womens Health. 2023. PMID: 37915037 Free PMC article.
-
Risk Factors and Survival Impact Associated With Documentation of Radiation Therapy Refusal in Patients With Gynecologic Cancer.Int J Radiat Oncol Biol Phys. 2024 Feb 1;118(2):427-435. doi: 10.1016/j.ijrobp.2023.08.052. Epub 2023 Aug 30. Int J Radiat Oncol Biol Phys. 2024. PMID: 37657506 Free PMC article.
-
Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.Am J Obstet Gynecol. 2020 Sep;223(3):398.e1-398.e18. doi: 10.1016/j.ajog.2020.02.041. Epub 2020 Mar 3. Am J Obstet Gynecol. 2020. PMID: 32142825 Free PMC article.
-
Guideline-concordant endometrial cancer treatment and survival in the Women's Health Initiative Life and Longevity After Cancer study.Int J Cancer. 2020 Jul 15;147(2):404-412. doi: 10.1002/ijc.32740. Epub 2019 Oct 31. Int J Cancer. 2020. PMID: 31618444 Free PMC article.
References
-
- Siegel RL, Miller MD, Jemal A. Cancer statistics. CA Cancer J Clin. 2017;2017:7–30. - PubMed
-
- Uterine neoplasms. NCCN Clinical Practice Guidelines in Oncology. Available at: https://www.nccn.org/professionals/physician_gls/pdf/uterine.pdf (accessed on 12/18/2016).
-
- Wright JD, Barrena Medel NI, Sehouli J, Fujiwara K, Herzog TJ. Contemporary management of endometrial cancer. Lancet. 2012; 379:1352–1360. - PubMed
-
- Meyer LA, Bohlke K, Powell MA, et al. Postoperative radiation therapy for endometrial cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the american society for radiation oncology evidence-based guideline. J Clin Oncol. 2015;33:2908–2913. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources